A Study of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Pemafibrate in Patients With Nonalcoholic Fatty Liver Disease.
Epistemonikos ID: 28ebffe384e4b2431167094d470de180675d93df
First added on: May 21, 2024